Market Size of Alopecia Treatment (Hair Loss) Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Alopecia Treatment (Hair Loss) Market Analysis
Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues. A sedentary lifestyle and unhealthy diets are leading to loss of hair among masses. Furthermore, aging and hormonal imbalance, increasing chronic diseases like arthritis, cancer, hypertension, depression also leads to hair loss, especially among the middle-aged population. According to the American Hair Loss Association, androgenetic alopecia accounts for over 95% of hair loss in men. Over 800 thousand patients are seeking some kind of treatment for hair loss worldwide.
In recent years, many novel drugs have been approved by the regulatory bodies for the treatment of alopecia and many drugs are in pipeline, which are expected to receive approval in the near future. Concert Pharmaceuticals Inc. received fast track designation from the United States Food and Drug Administration, (FDA) for its novel product for the treatment of moderate-to-severe alopecia areata in January 2018. The launches of such novel products in the market is expected to drive the global alopecia treatment market growth in the near future.
Alopecia Treatment (Hair Loss) Industry Segmentation
As per the scope of the report, alopecia treatment (Hair Loss) is the drugs that are indicated for the treatment of alopecia. The alopecia treatment (hair loss) drugs, like minoxidil, finasteride, and cyclosporine, which are indicated for the treatment of alopecia are covered. Alopecia also called hair-loss or baldness is a medical condition that refers to the loss of hair from the head or any part of the body.
| By Disease Type | |
| Androgenic Alopecia | |
| Alopecia Areata | |
| Ciatricial Alopecia | |
| Traction Alopecia | |
| Alopecia Totalis |
| By Gender | |
| Male | |
| Female |
| By Route of Administration | |
| Oral | |
| Topical | |
| Injectable |
| By Distribution Channel | |
| Hospitals | |
| Retail Pharmacies | |
| Online Pharmacies |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Alopecia Treatment (Hair Loss) Market Size Summary
The alopecia treatment market is experiencing significant growth driven by increasing awareness and the development of novel therapeutics. Alopecia, characterized by excessive hair loss due to medical conditions or dietary issues, is prevalent among various demographics, particularly middle-aged individuals facing hormonal imbalances and chronic diseases. The market is witnessing a surge in demand for treatments, with a notable portion of the female population seeking solutions due to the emotional and social impact of hair loss. The approval of new drugs and ongoing research are expected to further propel market expansion, with North America leading due to its advanced healthcare infrastructure and high treatment rates.
The market landscape is competitive, with key players like Sun Pharmaceuticals Industries Ltd., Aclaris Therapeutics Inc., and Concert Pharmaceuticals Inc. actively developing and marketing advanced products. The presence of high awareness levels and the frequency of conditions like Polycystic Ovary Syndrome (PCOS) contribute to the significant market share held by women. The United States, with its high prevalence of alopecia areata, serves as a major driver for the North American market. The strategic focus on innovative product development and regulatory approvals, such as orphan drug designations, underscores the dynamic nature of the alopecia treatment industry.
Alopecia Treatment (Hair Loss) Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Alopecia
-
1.2.2 Increasing R&D Initiatives and New Product Launches and Approvals
-
-
1.3 Market Restraints
-
1.3.1 Patent Expiry of Many Blockbuster Drugs
-
1.3.2 Side Effects Associated with the Available Hair Loss Treatment Therapies
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Disease Type
-
2.1.1 Androgenic Alopecia
-
2.1.2 Alopecia Areata
-
2.1.3 Ciatricial Alopecia
-
2.1.4 Traction Alopecia
-
2.1.5 Alopecia Totalis
-
-
2.2 By Gender
-
2.2.1 Male
-
2.2.2 Female
-
-
2.3 By Route of Administration
-
2.3.1 Oral
-
2.3.2 Topical
-
2.3.3 Injectable
-
-
2.4 By Distribution Channel
-
2.4.1 Hospitals
-
2.4.2 Retail Pharmacies
-
2.4.3 Online Pharmacies
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle-East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle-East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Alopecia Treatment (Hair Loss) Market Size FAQs
What is the current Alopecia Treatment (Hair Loss) Market size?
The Alopecia Treatment (Hair Loss) Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)
Who are the key players in Alopecia Treatment (Hair Loss) Market?
Sun Pharmaceuticals Industries Ltd., Johnson & Johnson, Concert Pharmaceuticals Inc., Cipla Inc. and Daiichi Sankyo are the major companies operating in the Alopecia Treatment (Hair Loss) Market.
